Advisor Group’s AbbVie ABBV Stock Holding History

Advisor Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Hold	6	–	–	﹤0.01%	4943
2019 Q3	$1K	Buy	+6	New	+$411	﹤0.01%	5065

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Advisor Group's ABBV Position: Q4 2019 in Review

Advisor Group increased its AbbVie (ABBV) stake by 7.1% in Q4 2019, buying an estimated $1.68M and bringing the position to 304,741 shares worth $27M. The position accounts for 0.19% of the portfolio, ranked #100.

Advisor Group first reported a position in ABBV in Q2 2016 and has held it in 15 quarters since. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

Advisor Group held 304,741 shares of AbbVie worth $27M as of Q4 2019.
Advisor Group bought 20,248 AbbVie shares in Q4 2019, an estimated $1.68M.
AbbVie made up 0.19% of Advisor Group's portfolio in Q4 2019, its #100 holding.
Advisor Group first reported a position in AbbVie in Q2 2016 and has held it in 15 quarters since.
2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.